Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/16488
Título : | Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium | Autor : | Erausquin, Gabriel A. de Snyder, Heather M. Brugha, Traolach S. Seshadri, Sudha Carrillo, María Sagar, Rajesh Huang, Yueqin Newton, Charles Tartaglia, Carmela Teunissen, Charlotte Håkanson, Krister Akinyemi, Rufus Prasad, Kameshwar D'Avossa, Giovanni Gonzalez Aleman, Gabriela Hosseini, Akram Vavougios, George D. Sachdev, Perminder Bankart, John Mors, Niels Peter Ole Lipton, Richard Katz, Mindy Fox, Peter T. Katshu, Mohammad Zia Iyengar, M Sriram Weinstein, Galit Sohrabi, Hamid R. Jenkins, Rachel Stein, Dan J. Hugon, Jacques Mavreas, Venetsanos Blangero, John Cruchaga, Carlos Krishna, Murali Wadoo, Ovais Becerra, Rodrigo Zwir, Igor Longstreth, William T. Kroenenberg, Golo Edison, Paul Mukaetova-Ladinska, Elizabeta Staufenberg, Ekkehart Figueredo Aguiar, Mariana Yécora, Agustín Vaca, Fabiana Zamponi, Hernan P. Lo Re, Vincenzina Majid, Abdul Sundarakumar, Jonas González, Héctor M. Geerlings, Mirjam I. Skoog, Ingmar Salmoiraghi, Alberto Boneschi, Filippo Martinelli Patel, Vibuthi N. Santos, Juan M. Arroyo, Guillermo Rivera Moreno, Antonio Caballero Felix, Pascal Gallo, Carla Arai, Hidenori Yamada, Masahito Iwatsubo, Takeshi Sharma, Malveeka Chakraborty, Nandini Ferreccio, Catterina Akena, Dickens Brayne, Carol Maestre, Gladys Blangero, Sarah Williams Brusco, Luis I. Siddarth, Prabha Hughes, Timothy M. Zuñiga, Alfredo Ramírez Kambeitz, Joseph Laza, Agustin Ruiz Allen, Norrina Panos, Stella Merrill, David Ibáñez, Agustín Tsuang, Debby Valishvili, Nino Shrestha, Srishti Wang, Sophia Padma, Vasantha Anstey, Kaarin J. Ravindrdanath, Vijayalakshmi Blennow, Kaj Mullins, Paul Łojek, Emilia Pria, Anand Mosley, Thomas H. Gowland, Penny Girard, Timothy D. Bowtell, Richard Vahidy, Farhaan S. |
Palabras clave : | COVID-19; DEMENCIA; DISCAPACIDAD INTELECTUAL; ENFERMEDAD DE ALZHEIMER | Fecha de publicación : | 2022 | Editorial : | Wiley Alzheimer’s Association |
Cita : | Erausquin, G.A., et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium [en línea]. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2022, 8(1) doi:10.1002/trc2.12348 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/16488 | Resumen : | Abstract: Coronavirus disease 2019 (COVID-19) has caused >3.5 million deaths worldwide and affected >160 million people. At least twice as many have been infected but remained asymptomatic or minimally symptomatic. COVID-19 includes central nervous system manifestations mediated by inflammation and cerebrovascular, anoxic, and/or viral neurotoxicity mechanisms. More than one third of patients with COVID-19 develop neurologic problems during the acute phase of the illness, including loss of sense of smell or taste, seizures, and stroke. Damage or functional changes to the brain may result in chronic sequelae. The risk of incident cognitive and neuropsychiatric complications appears independent from the severity of the original pulmonary illness. It behooves the scientific and medical community to attempt to understand the molecular and/or systemic factors linking COVID-19 to neurologic illness, both short and long term. Methods This article describes what is known so far in terms of links among COVID-19, the brain, neurological symptoms, and Alzheimer's disease (AD) and related dementias. We focus on risk factors and possible molecular, inflammatory, and viral mechanisms underlying neurological injury. We also provide a comprehensive description of the Alzheimer's Association Consortium on Chronic Neuropsychiatric Sequelae of SARS-CoV-2 infection (CNS SC2) harmonized methodology to address these questions using a worldwide network of researchers and institutions. Results Successful harmonization of designs and methods was achieved through a consensus process initially fragmented by specific interest groups (epidemiology, clinical assessments, cognitive evaluation, biomarkers, and neuroimaging). Conclusions from subcommittees were presented to the whole group and discussed extensively. Presently data collection is ongoing at 19 sites in 12 countries representing Asia, Africa, the Americas, and Europe. Discussion The Alzheimer's Association Global Consortium harmonized methodology is proposed as a model to study long-term neurocognitive sequelae of SARS-CoV-2 infection. | URI : | https://repositorio.uca.edu.ar/handle/123456789/16488 | ISSN : | 2352-8737 | Disciplina: | MEDICINA | DOI: | 10.1002/trc2.12348 | Derechos: | Acceso abierto |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
chronic-neuropsychiatric-sequelae.pdf | 2,42 MB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
72
comprobado en 27-abr-2024
Descarga(s)
52
comprobado en 27-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons